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Toxoplasma gondii:
An Atypical Presentation of Optic Neuritis
Nicky R. Holdeman, OD, MD; Steven Burnham, BSc;
R. Alejandro Cruz, MD; Rosa A. Tang, MD, MPH, MBA

ABSTRACT
Toxoplasma gondii is a parasite whose natural host is

the caL Ocular toxoplasmosis can be categorized into
two forms of infections: congenital, where an infant is
infected in utero; and acquired, where an individual is
typically infected by ingesting food contaminated with
T. gondii oocytes. Although acquired infections are
uncommon in the United States, toxoplasmosis should
remain in the differential diagnosis of an infectious
optic neuritis.
The typical manifestation of toxoplasmosis is a
retinochoroidltis, with a "headlight in the fog" appearance, due to dense inflammation of the vitreous;
consequently, the diagnosis is often made clinically.
This case describes a healthy 36-year-old Hispanic male
who had an atypical presentation of ocular toxoplasmosis, with minimal vitritis and papillomacular
involvement; thus serology was necessary for a definitive
diagnosis. Treatment led to a rapid improvement in

vision and ultimately a good prognosis.
INTRODUCTION
Toxop/asma gondii is an obligate intracellular protozoan
parasite. Nearly one third of humanity has been exposed
to this organism; however, only l % to 3% will develop
ocular manifestations. 1·l Despite the relatively low rate of
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ocular involvement, T. gondii is one of the leading causes
of posterior uveitis and is the leading cause of infectious
retinochoroiditis worldwide. "1 The natural host of T.
gondii is the feline family. Via fecal matter, cats release
oocysts into the environment, which can remain viable for
extended periods. Humans typically acquire infection by
ingesting the oocysts found in contaminated soil, fruits,
vegetables and undercooked meats or through congenital
transmission in utero.4 The oocysts develop into tachyzoites,
the primary infectious form of T. gondii, which cause
acute tissue destruction and inflammation. Tachyzoites
then transfonn into bradyzoites, which fonn protective
cysts and may remain donnant until a precipitating event
causes reactivation. i
CASE STUDY
A 36-year-old, healthy Hispanic male presented to a local

optometrist with complaints of an acute onset of constant,
blurred vision and "black specks" in the left eye that
started earlier that morning. Prior lo this event, the patient
had never experienced any vision abnormalities. His
family ocular and medical history was unremarkable.
He was not using any medications and had no known drug
or environmental allergies. The patient was a police
officer who had never smoked and consumed aJcohol only
occasionally. He denied any sexually transmitted diseases.
Unaided acuities were 6/4.5- (20/15-) in the right eye
and 6/6- (20/20-) in the left; refraction yielded a low
simple hyperopia in both eyes. Gross inspection and slit
lamp examination were unremarkable, with no cells
detected in the anterior chamber or in the vitreous in either
eye. Ophthalmoscopy revealed no abnonnalities in the right
eye but disclosed optic nerve edema in the left eye.
Humphrey visual field, (HVF) 24-2 SITA Fast of the right
eye was nonnal, but did show a generalized depression, with
an enlarged blind spot in the left eye (Fig. l ).
Following the examination, further discussion revealed
a history of cold sores, with a recent labial infection. The
patient also reported that he had experienced flu-like
symptoms, with a low-grade fever, which had persisted for
approximately two months. In addition, he noted that his
daughter and his stepdaughter both had cats, but he denied
changing the litter or having any close contact with either
pet Lastly, he acknowledged that he enjoyed hunting and
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Rg, 1 Initial Hum~ Wilial field 24·2 SITA-Fast, perfooned by the referring
optometnst, sto.wd an OYerall depressioo and llfllaryed blind spot In the left
eye The rti;lt WitJal field w a s ~ and was not ltiooed.

had recently handled deer meat The patient was referred to
his primary care physician (PCP), with a recommendation
to obtain an MRl of the brain and orbits.
An MRI, with and without contras!, was perfonned
as well as a CBC, CRP, ESR, thyroid panel, lipid profile
and hepatic function testing. The MRI of the brain and
orbits was unremarkable and clinical pathology revealed
no abnormalities. Over the course of the following week,
the patient's symptoms gradually worsened but there were
no significant changes noted upon examination.
A referral was then made to a neuro-ophthalmologist,
who noted a 0.6 log unit afferent pupillary defect (APD),
I+ vitrcal cells, and 4+ optic nerve edema in the left eye;
examination of the right eye was unremarkable (Fig. 2). A
visually evoked polential showed nonnal implicit times
and amplitudes in both eyes. A multifocal electrorelinogram (mfERG) was nonnal in the right eye bul there was
a reduced response in the inferior temporal field in the left
eye (Fig. 3). Optical coherence tomography (OCT) of the
right eye was nonnal but the left eye had significant
subretinal fluid in the superior papillomacular bundle
(Fig. 4). Intravenous fluorescein angiography (IVFA)
showed no abnonnalities in the right eye, but disclosed
diffuse leakage of the left optic disc, with no vascular or
macular irregularities (Fig. 5). With evidence of an
inflammatory process, a chest X-ray, PPD, ACE levels,
RPR, FrA-AB S, HIV testing, Banonella antibodies, and
Toxoplasma antibodies were requested. The patient was
prescribed oral azithromycin while awaiting the results of
the ancillary tests.
Twelve days after the initial presentation, the patient
requested to be seen emergently due to a sudden change
in vision. His BCVAs remained 6/6 (20/20) in the right
eye, but had declined 10 6/(IJ (20/200), with eccentric

Ag. 2 Al the Initial neuro-ophlhalmology visit, there was massive edema
of the lelt optic nerve, with perl-paplllary and pre-retinal hemorrhages, as
wenas venous engorgement and a large area of serous fluid supero•
temporally suggestive of neuroretlnlUs. The right eye was unremarkable.

fixation, in the left The APD in the left eye had
progressed to 0.9 log units and color perception by HRR
plates was decreased in the left eye. Amsler grid showed
a defect in the temporal half of the left eye and a HVF 24-2
SITA Fast disclosed a generalized, relative, deep scotom a
centered on the blind spot in the left eye (Fig. 6). The
visual field of the right eye had low test reliability,
but showed no signific ant defects . A repeat OCT
demonstrated persistent subretinal fluid in the papillomacular bundle of the left eye, while the right eye
remained unremarkable (Fig. 7).
The patient was admitted to the hospital for observation. Soon thereafter, testing revealed T. gondii IgG and IgM
antibodies, indicating a recently acquired toxoplasmosis
infection. The patient was given a five-day course of
pyrimetharnine, sulfadiazine, leucovorin calcium, methylprednisolone succinate, valacyclovir, and pantoprazole. The
patient was referred to the Center for Disease Control for
evaluation of long-tenn antibiotic treatment
The patient was last seen for a scheduled follow-up
evaluation four months after the initial onset. Bestcorrected visual acuities were now 6/6 (20/20) in both
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Fig. 3 MulUfocal electroreUnograrn of the right eye was normal but demonstrated reduced responses centrally and In the Interior-temporal quadrant of
the left eye.
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Fig, 4 Optical coherence tomography of the right eye was normal but the left eye had significant elevation of the optic nerve, with subretfnal Huld In the
superior paplllomacular bundle.

eyes. There was significant reduction in the optic nerve
edema of the left eye, resolution of the pre-retinal and
retinal hemorrhages, with mild residual retinal scarring
(Figs. 8, 9). Humphrey visual fields demonstrated
improvement in the left eye compared to prior testing
(Fig. l 0). Initial findings of what may have progressed to
a necrotic and non-resolving neuro-retinitis secondary to
a T. gondii infection were almost entirely resolved.
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DISCUSSION

Although acquired T. gondii is rare in the United States,
it is still a potential cause of infectious optic neuritis, as
demonstrated by this case. Clinicians often diagnose ocular
toxoplasmosis based on the signs of active retinochoroidal
lesions, vitreous inflammation, and a "headlight in the fog"
appearance, all of which are commonly found in immunocompetent patients.1.s.6 However, this healthy male had

J

Fig. 5 Intravenous fluoresceln angiography showed no abnormalities In the right eye, but disclosed diffuse leakage ot the left optic disc, with no
vascular or macular Irregularities.
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Fig. 6 Humphrey visual field 24~2 SITA Fast of the felt eye showing a
deep, arcuate defect surrounding the left blind spot and encroaching
central vision

minimal vitritis, with optic nerve involvement, which is
an unusual presentation for toxoplasmosis.i Despite
lack of significant vitreous inflammation, there is not
necessarily reason to suspect that every patient is
immunocompromised. It has been reported that deep
retinal lesions (i.e., punctate outer retinal toxoplasmosis)
are often associated with less vitreous inflammation,
as in this case.' This atypical manifestation required the
exclusion of other infectious entities that can produce an
optic neuritis, such as toxocariasis, cat scratch disease,
tuberculosis, sarcoidosis, Lyme disease, syphilis, herpes,
or cytomegalovirus.0.1 Serology is supportive and the
presence of lgM antibodies, detected by IFA and ELISA
testing, indicates the presence of a recent infection.
However, these tests are not diagnostic in every situation,
as 20% to 70% of the general population can show
positive titers.• It may be necessary to confinn difficult or

atypical cases with paracentesis of the anterior chamber,
using polymerase chain reaction, to detect T. gondii DNA
in the aqueous.',.
Indications for treatment vary considerably between
practitioners! despite the fact that more than 94% of
patients with ocular toxoplasmosis will have permanent
visual defects, per automated perimetry.10 Many clinicians
opt to monitor a peripheral lesion in an immunocompetent
individual with good acuities, as the infections are typically
self limiting•' However, reduced acuities, associated with
lesions threatening major vessels, the optic nerve, and/or
perifoveal areas, are indicators for treatment, as was seen
in this case. 1.1 Treatment of vision threatening toxoplasmosis typically includes some combination of antimicrobial and anti-parasitic agents, although their
efficacy has not been proven in clinical trials. 11 Choices
often involve a multidrug approach including pyrimethamine, with some combination of azithromycin, sulfadiazine, clindamycin, or sulfamethoxazole/trimethoprim.
Patients treated with pyrimethamine should also receive
folinic acid (leucovorin calcium) to minimize bone
marrow suppression. 1•7•11•12 The use of oral prednisone, with
concurrent antimicrobial treatment, may be beneficial in
immunocompetent patients, especially when there is optic
nerve and/or macular involvement. 1·1 However, one must
consider that systemic therapy is expensive and can have
significant side effects. A viable and potentially safer
option for patients who cannot tolerate systemic therapy,
is a combination of clindamycin and dexamethasone
given as an intravitreal injection. 1 u Longer-term treatment
of ocular toxoplasmosis is aimed at reducing the severity
and frequency of recurrences. Use of intermittent
trimethoprim/sulfamethoxazole for several months has
been shown to reduce the rate of recurrence.,....
Management of choroidal neovascularization includes
photodynamic therapy or anti-VEGF agents (intravitreal
bevacizumab or ranibizumab). 1•1'- 11
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Fig. 7 Repeat opUcal coherence tomography documented persistent sub-retinal fluid In the paplllomacular bundle, with a serous retinal detachment of
the rett eye, while the right eye remained within normal limits.

fig. 8 Several weeks following treatment, OCT showed significant reduction of optic nerve edema, mild retinal scarring. and gradual dissipation of serous
Nuld In the left eye.

The ocular complications associated with toxoplasmosis include risk of recurrence, visual field defects,
retinal detachment, sub-retinal neovascular membranes,
cataracts, cystoid macular edema, papillitis, glaucoma,
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and chronic posterior uveitis. 1' Since this patient had a
newly acquired lesion, with optic nerve and macular
involvement, frequent progress exams were indicated to
properly manage potential complications. Fortunately,
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Fig. 9 Fundus photography of the left eye, four months after onset of
symptoms, showed resoluUon of opUc nerve edema, fading of pre-reUna!
and reUnal hemorrhages and mild residual reUnal scarring.

Fig. 10 Humphrey visual field 24-2 SITA Fast showed a persistent Inferior
arcuate defect in the left eye, but was somewhat improved compared to
prior tests.

early diagnosis and intervention led lo a good visual
prognosis.
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CONCLUSION
Although acquired ocular toxoplasmosis is uncommon in
the United States, infection via contaminated food or
water does occur.'"·'" Consequently, clinicians should con
sider toxoplasmosis in cases of atypical optic neuritis and
use appropriate tests to assist in the diagnosis and man
agement. CJ
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